Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria
Learn more about:
Related Clinical Trial
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=2 Years to
A Study to Evaluate THB001 in Adult Patients With Chronic Cold Urticaria
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria